The Patent Finder

Medifron DBT Inc.

Also on record
Records under this name other than the patents Medifron DBT Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Showing 1 to 5 of 5 · Back to Medifron DBT Inc.

PatentTitleStatus Expires Confidence
US 8,580,848Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof
Lapsed on the fee record
Ended Nov 12, 2017 · From the USPTO record
Lapsed on the fee recordEnded Nov 12, 2017From the USPTO record
US 8,507,553Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof
Lapsed on the fee record
Ended Aug 13, 2017 · From the USPTO record
Lapsed on the fee recordEnded Aug 13, 2017From the USPTO record
US 8,455,542Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof
Lapsed on the fee record
Ended Jun 4, 2017 · From the USPTO record
Lapsed on the fee recordEnded Jun 4, 2017From the USPTO record
US 6,476,076Vanilloid analogues containing resinferatoxin pharmacophores as potent vanilloid receptor agonists and analgesics, compositions and uses thereof
Lapsed on the fee record
Ended Nov 5, 2014 · From the USPTO record
Lapsed on the fee recordEnded Nov 5, 2014From the USPTO record
US 6,872,748Simplified resiniferatoxin analogues as vanilloid receptor agonist showing excellent analgesic activity and the pharmaceutical compositions containing the same
Lapsed on the fee record
Ended Mar 29, 2013 · From the USPTO record
Lapsed on the fee recordEnded Mar 29, 2013From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited